NCT04618081View on ClinicalTrials.gov

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

CompletedOBSERVATIONAL

Enrollment

151

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

March 27, 2025

Study Completion Date

March 27, 2025

Conditions

Lymphoma Nonhodgkin

Trial Locations (1)

Unknown

Local Institution, Japan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY